Literature DB >> 18359976

Pharmacoadherence: a new term for a significant problem.

Marie A Chisholm-Burns1, Christina A Spivey.   

Abstract

Mesh：

Year:  2008        PMID： 18359976     DOI： 10.2146/ajhp070372

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  9 in total

1.  Rethinking Adherence: A Proposal for a New Approach to Risk Assessment.

Authors:  Abby R Rosenberg; Catherine Fiona Macpherson; Leah Kroon; Rebecca Johnson
Journal:  J Adolesc Young Adult Oncol       Date:  2013-06       Impact factor: 2.223

2.  Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.

Authors:  David C Klonoff; Jennifer Y Zhang; Trisha Shang; Chhavi Mehta; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2020-12-08

3.  Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients.

Authors:  Marie A Chisholm-Burns; Christina A Spivey; Praveen K Potukuchi; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Nephron       Date:  2020-05-20       Impact factor: 2.847

Review 4.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

5.  What are the important design features of personal health records to improve medication adherence for patients with long-term conditions? A systematic literature review.

Authors:  Elisavet Andrikopoulou; Philip Scott; Helena Herrera; Alice Good
Journal:  BMJ Open       Date:  2019-09-26       Impact factor: 2.692

6.  Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study.

Authors:  Sherine Ismail; Abrar Al-Subhi; Eman Youssif; Medhat Ahmed; Abdullah Almalki; Diane L Seger; Andrew C Seger; Earl Cook
Journal:  BMC Nephrol       Date:  2019-11-13       Impact factor: 2.388

7.  Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension.

Authors:  Walnéia Aparecida de Souza; Maricene Sabha; Fabrício de Faveri Favero; Gun Bergsten-Mendes; Juan Carlos Yugar-Toledo; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

8.  Ten lessons learned from conducting an adherence intervention trial.

Authors:  Jeannie K Lee; Karen A Grace; Allen J Taylor
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

9.  The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke.

Authors:  Bipin B Bhakta; Suzanne Hartley; Ivana Holloway; J Alastair Couzens; Gary A Ford; David Meads; Catherine M Sackley; Marion F Walker; Sharon P Ruddock; Amanda J Farrin
Journal:  Trials       Date:  2014-08-08       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.